Effects of imatinib mesylate on cutaneous neurofibromas associated with neurofibromatosis type 1.

MLA

Yasuda, Ken‐ichi, et al. “Effects of Imatinib Mesylate on Cutaneous Neurofibromas Associated with Neurofibromatosis Type 1.” Clinical Case Reports, vol. 8, no. 11, Nov. 2020, pp. 2125–28. EBSCOhost, https://doi.org/10.1002/ccr3.3071.

APA

Yasuda, K., Nobeyama, Y., Ishiji, T., Ota, A., & Asahina, A. (2020). Effects of imatinib mesylate on cutaneous neurofibromas associated with neurofibromatosis type 1. Clinical Case Reports, 8(11), 2125–2128. https://doi.org/10.1002/ccr3.3071

Chicago

Yasuda, Ken‐ichi, Yoshimasa Nobeyama, Takaoki Ishiji, Arihito Ota, and Akihiko Asahina. 2020. “Effects of Imatinib Mesylate on Cutaneous Neurofibromas Associated with Neurofibromatosis Type 1.” Clinical Case Reports 8 (11): 2125–28. doi:10.1002/ccr3.3071.